rosuvastatin calcium tablet, film coated
proficient rx lp - rosuvastatin calcium (unii: 83mvu38m7q) (rosuvastatin - unii:413kh5zj73) - pediatric use information for patients 7 to 17 years of age is approved for astrazeneca’s crestor (rosuvastatin calcium) tablets. however, due to astrazeneca’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. rosuvastatin is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia. rosuvastatin is indicated as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia (type iii hyperlipoproteinemia). rosuvastatin is indicated as adjunctive therapy to other lipid-lowering treatments (e.g., ldl apheresis) or alone if such treatments are unavailable to reduce ldl-c, total-c, and apob in adult patients with homozygous familial hypercholesterolemia. rosuvastatin has not been studied in fredrickson type i and vdyslipidemias. rosuvastatin is contraindicated in the following conditions: • patients with a known hypersensitivity to any component of this product. hypersensitivity reaction
rosuvastatin calcium tablet, film coated
bryant ranch prepack - rosuvastatin calcium (unii: 83mvu38m7q) (rosuvastatin - unii:413kh5zj73) - pediatric use information for patients 7 to 17 years of age is approved for astrazeneca’s crestor (rosuvastatin calcium) tablets. however, due to astrazeneca’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. rosuvastatin is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia. rosuvastatin is indicated as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia (type iii hyperlipoproteinemia). rosuvastatin is indicated as adjunctive therapy to other lipid-lowering treatments (e.g., ldl apheresis) or alone if such treatments are unavailable to reduce ldl-c, total-c, and apob in adult patients with homozygous familial hypercholesterolemia. rosuvastatin has not been studied in fredrickson type i and v dyslipidemias. rosuvastatin is contraindicated in the following conditions: • patients with a known hypersensitivity to any component of this product. hypersensitivity reactio
rosuvastatin calcium tablet, film coated
bryant ranch prepack - rosuvastatin calcium (unii: 83mvu38m7q) (rosuvastatin - unii:413kh5zj73) - pediatric use information for patients 7 to 17 years of age is approved for astrazeneca’s crestor (rosuvastatin calcium) tablets. however, due to astrazeneca’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. rosuvastatin is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia. rosuvastatin is indicated as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia (type iii hyperlipoproteinemia). rosuvastatin is indicated as adjunctive therapy to other lipid-lowering treatments (e.g., ldl apheresis) or alone if such treatments are unavailable to reduce ldl-c, total-c, and apob in adult patients with homozygous familial hypercholesterolemia. rosuvastatin has not been studied in fredrickson type i and v dyslipidemias. rosuvastatin is contraindicated in the following conditions: • patients with a known hypersensitivity to any component of this product. hypersensitivity reactio
rosuvastatin calcium tablet, film coated
remedyrepack inc. - rosuvastatin calcium (unii: 83mvu38m7q) (rosuvastatin - unii:413kh5zj73) - pediatric use information for patients 7 to 17 years of age is approved for astrazeneca’s crestor (rosuvastatin calcium) tablets. however, due to astrazeneca’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. rosuvastatin is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia. rosuvastatin is indicated as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia (type iii hyperlipoproteinemia). rosuvastatin is indicated as adjunctive therapy to other lipid-lowering treatments (e.g., ldl apheresis) or alone if such treatments are unavailable to reduce ldl-c, total-c, and apob in adult patients with homozygous familial hypercholesterolemia. rosuvastatin has not been studied in fredrickson type i and v dyslipidemias. rosuvastatin is contraindicated in the following conditions: • patients with a known hypersensitivity to any component of this product. hypersensitivity reactio
chemmart rosuvastatin 20 mg rosuvastatin calcium 20 mg tablet blister pack
apotex pty ltd - rosuvastatin calcium -
chemmart rosuvastatin 40 mg rosuvastatin calcium 40 mg tablet blister pack
apotex pty ltd - rosuvastatin calcium -
terry white chemists rosuvastatin 10 mg rosuvastatin calcium 10 mg tablet blister pack
apotex pty ltd - rosuvastatin calcium -
chemmart rosuvastatin 10 mg rosuvastatin calcium 10 mg tablet blister pack
apotex pty ltd - rosuvastatin calcium -
terry white chemists rosuvastatin 5 mg rosuvastatin calcium 5 mg tablet blister pack
apotex pty ltd - rosuvastatin calcium -
chemmart rosuvastatin 5 mg rosuvastatin calcium 5 mg tablet blister pack
apotex pty ltd - rosuvastatin calcium -